Treatment of acute myeloid leukemia

被引：42
作者：
Estey, Elihu H. [1 ]
机构：
[1] Seattle Canc Care Alliance, Seattle, WA USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 01期
关键词：
RISK MYELODYSPLASTIC SYNDROME; ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; TRANS-RETINOIC ACID; CORE-BINDING-FACTOR; COMPLEX KARYOTYPE; ELDERLY-PATIENTS; DOSE CYTARABINE; CLINICAL-TRIALS; AML;
D O I：
10.3324/haematol.2008.001263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：10 / 16
页数：7
相关论文
共 50 条
[21]   FLT3-targeted treatment for acute myeloid leukemia [J].
Arai, Yasuyuki ;
Chi, SungGi ;
Minami, Yosuke ;
Yanada, Masamitsu .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (03) :351-363
[22]   Clofarabine: a new treatment option for patients with acute myeloid leukemia [J].
Larson, Melissa L. ;
Venugopal, Parameswaran .
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (08) :1353-1357
[23]   Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia [J].
DiNardo, Courtney D. ;
O'Brien, Susan ;
Gandhi, Varsha V. ;
Ravandi, Farhad .
FUTURE ONCOLOGY, 2013, 9 (08) :1073-1082
[24]   Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions [J].
DiNardo, Courtney ;
Lachowiez, Curtis .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (05) :386-394
[25]   Characteristics and Outcomes of Older Patients With Secondary Acute Myeloid Leukemia According to Treatment Approach [J].
Boddu, Prajwal Chaitanya ;
Kantarjian, Hagop M. ;
Ravandi, Farhad ;
Garcia-Manero, Guillermo ;
Verstovsek, Srdan ;
Jabbour, Elias J. ;
Takahashi, Koichi ;
Bhalla, Kapil ;
Konopleva, Marina ;
DiNardo, Courtney D. ;
Ohanian, Maro ;
Pemmaraju, Naveen ;
Jain, Nitin ;
Pierce, Sherry ;
Wierda, William G. ;
Cortes, Jorge E. ;
Kadia, Tapan M. .
CANCER, 2017, 123 (16) :3050-3060
[26]   Midostaurin treatment in FLT3-mutated acute myeloid leukemia and systemic mastocytosis [J].
Kayser, Sabine ;
Levis, Mark J. ;
Schlenk, Richard F. .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (11) :1177-1189
[27]   Treatment strategies for pediatric acute myeloid leukemia [J].
Absalon, Michael J. ;
Smith, Franklin O. .
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (01) :57-79
[28]   The role of quizartinib in the treatment of acute myeloid leukemia [J].
Ostronoff, Fabiana ;
Estey, Elihu .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (12) :1659-1669
[29]   Azacitidine for the treatment of patients with acute myeloid leukemia [J].
Maurillo, Luca ;
Venditti, Adriano ;
Spagnoli, Alessandra ;
Gaidano, Gianluca ;
Ferrero, Dario ;
Oliva, Esther ;
Lunghi, Monia ;
D'Arco, Alfonso M. ;
Levis, Alessandro ;
Pastore, Domenico ;
Di Renzo, Nicola ;
Santagostino, Alberto ;
Pavone, Vincenzo ;
Buccisano, Francesco ;
Musto, Pellegrino .
CANCER, 2012, 118 (04) :1014-1022
[30]   The Treatment of Elderly Patients With Acute Myeloid Leukemia [J].
Krug, Utz ;
Buechner, Thomas ;
Berdel, Wolfgang E. ;
Mueller-Tidow, Carsten .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (51-52) :863-U11
12345